Order results by:
| Issue | Title | |
| Vol 9, No 2 (2017) | Antiplatelet therapy strategies for ischemic stroke | Abstract similar documents |
| M. Yu. Maksimova, A. V. Fonyakin, L. A. Geraskina | ||
| "... The paper considers the key areas of antithrombotic platelet therapy for ischemic stroke ..." | ||
| Vol 1, No 1 (2009) | ANTITHROMBIC THERAPY IN THE PRIMARY PREVENTION OF STROKE | Abstract similar documents |
| I. S. Yavelov | ||
| "... clinical efficacy in patients with stroke risk factors (coronary heart disease, clinical signs of lower ..." | ||
| Vol 5, No 3 (2013) | The risk factors and mechanisms for development of stroke and its types during pregnancy and the possibilities of medical therapy | Abstract similar documents |
| Vitaly Borisovich Laskov | ||
| "... in different stages of pregnancy, which complicates problems in reducing the risk of their development ..." | ||
| Vol 5, No 2 (2013) | The key areas of medical therapy for ischemic stroke | Abstract similar documents |
| Andrei Viktorovich Fonyakin, L A Geraskina | ||
| "... The paper considers the main therapeutic and preventive areas of management of patients with stroke ..." | ||
| Vol 5, No 4 (2013) | Platelet antiaggregants in the treatment and prevention of ischemic stroke | Abstract similar documents |
| Andrei Viktorovich Fonyakin | ||
| "... trials. The benefits and risks of each agent are shown in both monotherapy and combination therapy ..." | ||
| Vol 1, No 3-4 (2009) | ANTITHROMBOCYTIC THERAPY IN THE SECONDARY PREVENTION OF ISCHEMIC STROKE | Abstract similar documents |
| A. V. Fonyakin, L. A. Geraskina | ||
| "... Approaches to preventing recurrent stroke by antithrombocytic therapy are shown to be as diverse ..." | ||
| Vol 4, No 2 (2012) | Evolution of cognitive deficit: mild and moderate cognitive impairments | Abstract similar documents |
| V V Zakharov | ||
| "... -dementia CIs. Moderate CIs are associated with the high risk of dementia (10—15% yearly). As of now ..." | ||
| Vol 14, No 3 (2022) | Possibilities of antiplatelet therapy in non-cardioembolic ischemic stroke | Abstract similar documents |
| M. Yu. Maksimova, A. S. Airapetova | ||
| "... to be effective for secondary prevention of non-cardioembolic IS. Intensive antiplatelet therapy reduces the risk ..." | ||
| Vol 2, No 2 (2010) | Antiaggregant therapy in neurological practice: objectives and possibilities | Abstract similar documents |
| E. V. Portnyagina, A. F. Portnyagin | ||
| "... Based on the data available in the literature, the authors consider the prevention of ischemic ..." | ||
| Vol 7, No 1 (2015) | Current therapy for chronic cerebrovascular attack | Abstract similar documents |
| A. A. Shmonin, V. S. Krasnov, I. A. Shmonina, E. V. Melnikova | ||
| "... ; and neuroprotective therapy. Basic therapy for CCVA includes modification of risk factors, antihypertensive ..." | ||
| Vol 5, No 2S (2013): Special issue "Stroke" | Current approaches to antithrombotic therapy in patients with cardioembolic stroke | Abstract similar documents |
| Oleg Ivanovich Vinogradov, A N Kuznetsov, N V Rybalko | ||
| "... strokes are characterized by the higher magnitude of neurological deficit, the high risk of recurrent ..." | ||
| Vol 15, No 3 (2023) | Patient with non-cardioembolic ischemic stroke or high-risk transient ischemic attack. Part 2. Secondary prophylaxis | Abstract similar documents |
| A. A. Kulesh, S. N. Yanishevsky, D. A. Demin, L. I. Syromyatnikova, O. I. Vinogradov | ||
| "... or ticagrelor in minor IS or high-risk TIA; long-term dual antithrombotic therapy with acetylsalicylic acid ..." | ||
| Vol 3, No 4 (2011) | Current therapy for cognitive impairments | Abstract similar documents |
| N. V. Vakhnina | ||
| "... to the data of a number of investigations, the above measures reduce the risk of dementia, including ..." | ||
| Vol 8, No 4 (2016) | GLOBAL CLINICAL PRACTICE AND PERSONALIZED CHOICES FOR ORAL ANTICOAGULANT THERAPY FOR NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
| A. V. Fonyakin, L. A. Geraskina | ||
| "... The possibilities of antithrombotic therapy to prevent thromboembolic events in non-valvular ..." | ||
| Vol 5, No 2S (2013): Special issue "Stroke" | Post-stroke cognitive impairments: diagnosis and therapeutic approaches | Abstract similar documents |
| Natalia Vyacheslavovna Pizova | ||
| "... be as high as 80-90% and 7-23% of patients develop dementia. The most important risk factors for CI ..." | ||
| Vol 2, No 4 (2010) | Aprroaches to reducing the cardiovascular risk in the late periods of ischemic stroke | Abstract similar documents |
| A. V. Fonyakin, L. A. Geraskina, V. A. Shandalin | ||
| "... Basic antihypertensive, antithrombotic, and antihyperlipidemic therapies form the basis ..." | ||
| Vol 3, No 4 (2011) | Actual directions in the primary prevention of ischemic stroke | Abstract similar documents |
| A. V. Fonyakin, L. A. Geraskina | ||
| "... -risk strategies are identified in the system of primary prevention of stroke. The population strategy ..." | ||
| Vol 14, No 3 (2022) | Anticoagulant therapy as a part of secondary stroke prevention in patients with atrial fibrillation | Abstract similar documents |
| O. D. Ostroumova, T. M. Ostroumova | ||
| "... –35% of patients with IS, and its presence increases the risk of recurrent stroke compared ..." | ||
| Vol 9, No 3 (2017) | Current views of the risk factors, diagnosis, and therapy of Alzheimer's disease (according to the proceedings of the Alzheimer's Association International Conference, London, 2017) | Abstract similar documents |
| N. N. Koberskaya | ||
| "... in the elderly. The data of epidemiological and genetic studies and risk factors for AD were considered. Great ..." | ||
| Vol 7, No 4 (2015) | The clinical spectrum of non-dementia cognitive impairment: Subjective mild-to-moderate disorders | Abstract similar documents |
| V. V. Zakharov, N. V. Vakhnina, D. O. Gromova, N. E. Ter-Ovanesova, A. V. Tarapovskaya | ||
| "... criteria. There is evidence for the expediency of the earliest neuroprotective therapy to prevent dementia ..." | ||
| Vol 1, No 2 (2009) | ANTITHROMBOTIC THERAPY IN THE PREVENTION OF RECURRENT ISCHEMIC STROKE | Abstract similar documents |
| A. V. Fonyakin | ||
| "... The paper gives the current views of the role of antithrombotic therapy in the prevention ..." | ||
| Vol 14, No 6 (2022) | Features of pathogenesis and risk factors of in-hospital ischemic stroke | Abstract similar documents |
| S. V. Kolomentsev, N. V. Tsygan, I. A. Voznyuk, S. N. Yanishevskiy, E. I. Shermatyuk, O. M. Ilyina, I. V. Litvinenko | ||
| "... an additional role in the pathogenesis of IHIS, in addition to traditional risk factors. Objective: to study ..." | ||
| Vol 6, No 2 (2014) | Current approaches to the diagnosis, prevention, and therapy of cognitive impairments in vascular encephalopathy | Abstract similar documents |
| V.Yu. Lobzin, A.Yu. Emelin, S.V. Vorobyev, I.A. Lupanov | ||
| "... for their assessment are presented. Investigations of the prevention and drug therapy for this abnormality are detailed ..." | ||
| Vol 7, No 1 (2015) | Cardioembolic stroke | Abstract similar documents |
| I. V. Damulin, D. A. Andreev, Z. K. Salpagarova | ||
| "... The paper considers the main causes and pathogenetic, clinical, and therapeutic aspects ..." | ||
| Vol 13, No 5 (2021) | Anticoagulant therapy for stroke prevention in patients with severe COVID-19 | Abstract similar documents |
| A. T. Azimov, G. S. Rakhimbaeva, F. Z. Azimov | ||
| "... . The study included 509 patients, divided into three groups depending on the type of anticoagulant therapy ..." | ||
| Vol 12, No 4 (2020) | Drug-induced headache: an analysis of therapeutic strategies | Abstract similar documents |
| P. A. Merbaum, G. R. Tabeeva, A. V. Sergeev | ||
| "... the withdrawal period, risk factors for DIH recurrences, and ways of their prevention. ..." | ||
| Vol 6, No 3 (2014) | The risk factors and prevention of stroke in atrial fibrillation | Abstract similar documents |
| V. A. Parfenov, S. V. Verbitskaya | ||
| "... a relevant problem of modern medicine. Among the risk factors RFs) of stroke, nonvalvular atrial ..." | ||
| Vol 4, No 1 (2012) | Antyhypertensive therapy-based secondary prevention of ischemic stroke | Abstract similar documents |
| Vladimir Anatolyevich Parfenov, S V Verbitskaya, Yu A Starchina | ||
| "... by using antihypertensive therapy. It gives international guidelines and the results of randomized placebo ..." | ||
| Vol 9, No 3 (2017) | Vascular cognitive impairment, no dementia: diagnosis, prognosis, treatment, and prevention | Abstract similar documents |
| A. A. Kulesh, V. V. Shestakov | ||
| "... The paper considers the concept of vascular cognitive impairment (CI), no dementia ..." | ||
| Vol 6, No 2S (2014): Special issue "Stroke" | Arterial hypertension and stroke: cardiac and neurological aspects of secondary prevention | Abstract similar documents |
| L.A. Geraskina | ||
| "... This article considers the pathogenetic mechanisms of stroke in arterial hypertension (AH ..." | ||
| Vol 4, No 3 (2012) | Prevention and therapy of psychopathological disorders in patients with cardiovascular diseases | Abstract similar documents |
| Vladimir Ernstovich Medvedev | ||
| Vol 13, No 3 (2021) | Severity and treatment of cognitive impairment | Abstract similar documents |
| Yu. A. Starchina, V. V. Zakharov | ||
| "... is the leading risk factor for CI, the prevalence of which in the general population of people aged over 65 years ..." | ||
| Vol 13, No 5 (2021) | Antiplatelet therapy in stroke prevention after non-cardioembolic transient ischemic attack | Abstract similar documents |
| A. V. Fonyakin, L. A. Geraskina, M. Yu. Maksimova | ||
| "... The review shows modern concepts on the role of antiplatelet therapy in the secondary prevention ..." | ||
| Vol 5, No 1 (2013) | Bipolar affective disorders: the specific features of the course and maintenance pharmacotherapy | Abstract similar documents |
| Nina Arkadyevna Tyuvina, V N Smirnova | ||
| "... The paper reviews the literature on bipolar affective disorder (BAD). It considers the diagnosis ..." | ||
| Vol 14, No 4 (2022) | Control of dyslipidemia in the prevention of recurrent ischemic cerebrovascular accidents (expert opinion) | Abstract similar documents |
| M. M. Tanashyan, N. A. Shamalov, I. A. Voznyuk, S. N. Yanishevsky, O. I. Vinogradov, D. R. Khasanova, O. V. Tikhomirova, V. A. Parfenov, E. V. Oshchepkova, M. V. Ezhov, V. S. Gurevich, V. V. Arkhipov | ||
| "... stroke (IS) and transient ischemic attack (TIA) it is recommended to start or continue statin therapy ..." | ||
| Vol 13, No 5 (2021) | Treatment of cognitive impairment in arterial hypertension | Abstract similar documents |
| Yu. A. Starchina, K. S. Sleptcova | ||
| "... in patients with arterial hypertension. Arterial hypertension is a leading modifiable risk factor for stroke ..." | ||
| Vol 4, No 1 (2012) | Post-stroke epilepsy: predictors, risk factors, clinical types, treatment | Abstract similar documents |
| Tatyana Valeryevna Danilova, D R Khasanova, I R Kamalov | ||
| "... Cerebrovascular diseases are one of the most common risk factors of symptomatic epilepsy. The paper ..." | ||
| Vol 5, No 4 (2013) | Venous thromboses and thromboembolism in acute stroke: risk factors, diagnosis, treatment, and prevention | Abstract similar documents |
| Andrei Viktorovich Fonyakin, L A Geraskina | ||
| "... Stroke patients among all patients with somatic diseases are at one of the highest risks ..." | ||
| Vol 1, No 1 (2009) | THERAPY FOR EPILEPSY IN MIDDLE-AGED AND ELDERLY PATIENTS | Abstract similar documents |
| P. N. Vlasov, O. V. Andreeva | ||
| "... The authors consider the specific features of epilepsy in middle-aged and elderly patients ..." | ||
| Vol 16, No 6 (2024) | Comorbid disorders and their possible prevention in patients with vestibular vertigo | Abstract similar documents |
| O. V. Kosivtsova, Yu. A. Starchina, B. A. Shoev | ||
| "... of these symptoms, increase patient compliance with vestibular rehabilitation and reduce the risk of developing ..." | ||
| Vol 12, No 4 (2020) | Atrial fibrillation and cognitive impairment: cerebral microbleeds as a new risk factor and possibilities of anticoagulant therapy (Part 2) | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, T. M. Ostroumova | ||
| "... of disabled people. The specific feature of AF and CI is the presence of common risk factors. To date ..." | ||
| Vol 13, No 1 (2021) | Cognitive impairment in hypertension | Abstract similar documents |
| Yu. A. Starchina, V. V. Zakharov | ||
| "... and moderate CI. Hypertension is the main modifiable risk factor for stroke and cerebral small vessel damage ..." | ||
| Vol 6, No 3 (2014) | Current therapy for Parkinson's disease | Abstract similar documents |
| A. V. Obukhova | ||
| "... The main goal of therapy for Parkinson's disease (PD) is to correct dopamine deficiency ..." | ||
| Vol 10, No 2 (2018) | Pre-stroke cognitive impairment and its impact on medication adherence | Abstract similar documents |
| E. A. Kovalenko, A. N. Bogolepova | ||
| "... Adherence to long-term medication is one of the most important components of effective therapy ..." | ||
| Vol 7, No 2 (2015) | The fifth anniversary of clinical use of new oral anticoagulants in non-valvular atrial fibrillation | Abstract similar documents |
| A. V. Fonyakin | ||
| "... The possibilities of antithrombotic therapy for prevention of thromboembolic events in non ..." | ||
| Vol 15, No 5 (2023) | Non-specific neck pain (cervicalgia). Guidelines of the Russian Society for the Study of Pain (RSSP) | Abstract similar documents |
| V. A. Parfenov, N. N. Yakhno, M. L. Kukushkin, O. S. Davydov, M. V. Churyukanov, V. A. Golovacheva, G. Yu. Evzikov, A. I. Isaikin, M. A. Bakhtadze, L. A. Medvedeva, P. P. Kalinsky, V. A. Shirokov | ||
| "... . It is recommended to inform the patient with NNP about the favorable prognosis of the disease, its risk factors ..." | ||
| Vol 4, No 2 (2012) | Therapy for back pain syndrome | Abstract similar documents |
| E Yu Solovyeva | ||
| "... . To reduce the risk of adverse reactions of NSAID therapy, to enhance its adherence, and to reduce its cost ..." | ||
| Vol 10, No 4 (2018) | Therapy for acute nonspecific back pain: new additional opportunities | Abstract similar documents |
| V. A. Golovacheva, A. A. Golovacheva | ||
| "... their administration and larger doses, the higher the risk of side effects are. NSAIDs are contraindicated in some ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Non-drug therapies for cognitive impairment | Abstract similar documents |
| I. S. Preobrazhenskaya, D. Fantalis, S. A. Abdyshova, A. A. Kindarova | ||
| "... The review considers basic methods for non-drug correction of cognitive disorders, as well ..." | ||
| Vol 9, No 3 (2017) | A chronobiological approach to therapy for depression | Abstract similar documents |
| M. Yu. Gerasimchuk | ||
| "... of the existing genetic predisposition increases a risk for the occurrence and chronicity of depression. To solve ..." | ||
| Vol 12, No 3 (2020) | Effective methods for prevention of insomnia in motor drivers | Abstract similar documents |
| E. Z. Yakupov, A. V. Shulaev, A. A. Mardiev | ||
| "... This review considers obstructive sleep apnea syndrome (OSAS), one of the common causes ..." | ||
| Vol 5, No 3 (2013) | Prevention of venous thromboembolic events in ischemic stroke | Abstract similar documents |
| Vladimir Anatolyevich Parfenov | ||
| "... for prevention of VTEEs and their risk factors in this disease are analyzed. The prevention of VTEEs involves ..." | ||
| Vol 4, No 3 (2012) | A new era of anticoagulant therapy in the prevention of stroke in non-rheumatic atrial fibrillation | Abstract similar documents |
| Andrei Viktorovich Fonyakin, L A Geraskina | ||
| "... arrhythmia and a common cause of cardiogenic cerebral embolism. Oral anticoagulant therapy is a leader ..." | ||
| Vol 5, No 4 (2013) | Cardioembolic stroke: a variety of causes and current approaches to its prevention | Abstract similar documents |
| Lyudmila Aleksandrovna Geraskina | ||
| "... are presented; the specific features of antithrombotic therapy are analyzed in detail. ..." | ||
| Vol 1, No 3-4 (2009) | COMPLEX THERAPY FOR HYPERTENSIVE AND MIXED ENCEPHALOPATHY | Abstract similar documents |
| S. A. Rumyantseva | ||
| "... постоянной коррекции. Меры для профилактики и лечения всех сердечно-сосудистых заболеваний, в том числе ГЭ ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy | Abstract similar documents |
| S. N. Yanishevsky | ||
| "... of patients receiving vitamin K antagonists or NOACs. The results of studies assessing hypertension therapy ..." | ||
| Vol 15, No 5 (2023) | Migraine in perimenopausal women | Abstract similar documents |
| D. A. Klimentova, G. R. Tabeeva | ||
| "... to suffer from vasomotor symptoms. Hormone replacement therapy is prescribed to relieve vasomotor symptoms ..." | ||
| Vol 5, No 2 (2013) | Post-stroke cognitive impairments | Abstract similar documents |
| Elena Anatolyevna Katunina, L P Belikova, A A Makarova | ||
| "... дисбаланса, а также на профилактику повторных сосудистых эпизодов. ..." | ||
| Vol 17, No 2 (2025) | Interdisciplinary approach (neurologist and psychiatrist) in the treatment of chronic tension-type headaches | Abstract similar documents |
| K. M. Ashibokova, D. S. Petelin, O. N. Voskresenskaya, B. A. Volel | ||
| "... functioning 87,5±16,49 и 75±21,36; р<0,05). Similar trends were noted 6 months after initiation of therapy ..." | ||
| Vol 16 (2024): (Suppl. 2) | Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaya, E. V. Lysogorskaia, A. N. Boyko | ||
| "... Search for agents for the add-on therapy of multiple sclerosis (MS) that can enhance the effect ..." | ||
| Vol 4, No 1S (2012): Special issue "Epilepsy" | Adult epileptic patients’ perception of social support during rational antiepileptic therapy | Abstract similar documents |
| P. N. Vlasov, Z. S. Shakhabasova, V. M. Yaltonsky | ||
| "... member. The authors consider the main sources of social support (SS) to patients with epilepsy ..." | ||
| No 1S (2016): | Partial epilepsies: Choice of antiepileptic drugs in adults in the outpatient setting | Abstract similar documents |
| P. N. Vlasov | ||
| "... drug in his practice under present-day conditions. It considers possible clinical situations ..." | ||
| Vol 8, No 2 (2016) | Vascular and neurodegenerative cognitive impairments: a clinical case report | Abstract similar documents |
| V. V. Zakharov, N. V. Vakhnina | ||
| "... to consider the currently accepted approaches to the differential diagnosis of the most common nosological ..." | ||
| Vol 8, No 2 (2016) | Therapy for depression in bipolar affective disorder | Abstract similar documents |
| N. A. Tyuvina, I. G. Korobkova | ||
| "... into a therapy regimen does not significantly increase a risk for developing an inverse phase. ..." | ||
| Vol 10, No 3 (2018) | Current strategies to improve the efficiency and safety of prevention and treatment of embolic stroke in non-valvular atrial fibrillation: possibilities of neutralizing therapy | Abstract similar documents |
| S. N. Yanishevsky | ||
| "... to be substantially expanded now. Since it is necessary for recanalization therapy to block the effect ..." | ||
| Vol 7, No 1 (2015) | Possibility of predicting hemorrhagic transformation during reperfusion therapy for ischemic stroke in the patient population of the Sverdlovsk Region | Abstract similar documents |
| E. V. Prazdnichkova, A. M. Alasheev, A. A. Belkin, L. I. Volkova | ||
| "... of systemic thrombolytic therapy (TLT) for ischemic stroke (IS). Objective: to analyze the rates ..." | ||
| Vol 15, No 1 (2023) | New possibilities for the treatment of mild cognitive impairment and prevention of dementia in patients with cerebrovascular disease. Results of the PRIORITET Observation Program | Abstract similar documents |
| E. Y. Solovieva, P. R. Kamchatnov, L. B. Novikova, O. A. Kicherova, N. M. Khasanova | ||
| "... ) – allows a deeper study of the mechanisms of MCI formation. We consider the drug Prospecta as an effective ..." | ||
| Vol 11, No 4 (2019) | New possibilities for the therapy of secondary progressive multiple sclerosis | Abstract similar documents |
| A. M. Petrov, E. V. Ivashkova, I. D. Stolyarov | ||
| "... Patients with multiple sclerosis (MS) are at high risk for transition to secondary progressive MS ..." | ||
| Vol 7, No 2 (2015) | Falls and cerebellar ataxia | Abstract similar documents |
| I. V. Damulin | ||
| "... The paper considers the main causes of falls. Whatever their cause is, falls may lead to severe ..." | ||
| Vol 10, No 2 (2018) | Post-stroke dysphagia: novel treatment approaches | Abstract similar documents |
| M. M. Tanashyan, E. S. Berdnikovich, O. V. Lagoda | ||
| "... period of ischemic stroke. It considers the concurrent use of drug and speech therapies to improve ..." | ||
| 1 - 70 of 1077 Items | 1 2 3 4 5 6 7 8 9 10 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
